A Novel Pre-Vascularized Subcutaneous Site Safely Accommodates Stem Cell Derived Therapies for Treating Diabetes

Journal of Stem Cell and Transplantation Biology
doi 10.19104/jorm.2017.107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elyns Group LLC

Related search

Induced Pluripotent Stem (iPS) Cell–derived Pancreatic Β-Like Cells for Treating Diabetes

Science-Business eXchange
2010English

A Strategy Using Pluripotent Stem Cell-Derived Hepatocytes for Stem Cell-Based Therapies

2011English

Subcutaneous Adipose Tissue–Derived Stem Cell Utility Is Independent of Anatomical Harvest Site

BioResearch Open Access
BiochemistryGeneticsMolecular Biology
2015English

Subcutaneous Rituximab Can Be Safely Administered Without Pre-Medication

British Journal of Haematology
Hematology
2017English

Conventional and Novel Stem Cell Based Therapies for Androgenic Alopecia

Stem Cells and Cloning: Advances and Applications
MedicineCell Biology
2017English

Stem Cell-Based Therapies for Osteoarthritis: From Pre-Clinical to Clinical Applications

2017English

Potential for Stem Cell-Derived Biologic Pumps for Cardiovascular and Other Medical Therapies

Regenerative Medicine
EmbryologyBiomedical Engineering
2019English

Potential of Allogeneic Adipose-Derived Stem Cell – Hydrogel Complex for Treating Diabetic Foot Ulcers

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Stem Cell Therapy: Recent Success and Continuing Progress in Treating Diabetes

International Journal of Stem cell Research & Therapy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy